Elioda Tumwesigye
Born (1964-04-05) 5 April 1964
Sheema District, Uganda
NationalityUgandan
CitizenshipUganda
Alma materMakerere University
(Bachelor of Medicine and Bachelor of Surgery)
Case Western Reserve University
(Master of Science in epidemiology)
Occupation(s)Physician, Epidemiologist, Politician
Years activesince 1990
Known forPolitics
TitleCabinet Minister
SpouseJustine Tumwesigye

Elioda Tumwesigye is a Ugandan politician, physician, and epidemiologist who has served as minister of science, technology and innovation in the cabinet of Uganda since June 2016.[1] From March 2015 until June 2016, he served as the minister of health.[2]

Tumwesigye has been the elected member of parliament representing Sheema Municipality in Sheema District, since 2018.[3] From 25 July 2013 to 28 February 2015, he served as state minister for health (general duties).[4] He was promoted to minister of health on 1 March 2015,[5] taking a slot left vacant since 18 September 2014.[6]

Background and education

Tumwesigye was born in Sheema District on 5 April 1964 to Yekonia and Edinance Kasyamutwe. He was their second child. He attended Ntare School for his O-Level education, graduating in 1981, and for his A-Level studies where he was elected Head Boy and later graduated in 1984 as the third best performing student in the country. He obtained a Bachelor of Medicine and Bachelor of Surgery degree from Makerere University in 1990. While attending Makerere, he started the Sheema University Student's Association, which was still active as of March 2015. He was also elected health secretary of University Hall, a men's hall of residence at Makerere. In 1997, he obtained a Master of Science in epidemiology from Case Western Reserve University.[7]

Early career

From 1990 until 2001, he worked as a medical officer at the Uganda Ministry of Health, serving in the Epidemiology Studies Unit during the last four years. In 2001, he contested the parliamentary seat of Sheema County North, in Sheema District, on the National Resistance Movement political party ticket. He won and was re-elected in 2006 and 2011.[7]

Research

Through his career as a physician and epidemiologist, he has made substantial contribution through his research that is mostly about viral diseases which are published in some of the best journals in the world. Some of the articles include; Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda. This study provided detailed information on contact patterns and their spatial characteristics in an African setting.[8] An intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda. This study established that PrEP adherence intervention was feasible in a clinical trial of PrEP in Uganda and PrEP adherence increased after the intervention.[9] Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The data from this study reassured that oral PrEP delivery to women can continue without the need for concurrent testing for bacterial vaginosis or vaginal dysbiosis.[10] Low risk of Proximal Tubular Dysfunction associated with Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in men and women. the study found that daily oral FTC-TDF PrEP was not significantly associated with tubulopathy over the course of 24 months, nor did tubulopathy predict clinically relevant eGFR decline.[11] Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.[12] Household-Based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: A pilot evaluation.[13] Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in Serodiscordant partnerships.[14] Successful discontinuation of the Placebo Arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Pprtners PrEP study experience.[15] Effect of home-based HIV counselling and testing on stigma and risky sexual behaviours: serial cross-sectional studies in Uganda.[16] Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.[17] What's love got to do with It? explaining adherence to oral Antiretroviral Pre-exposure Prophylaxis (PrEP) for HIV Serodiscordant couples.[18] Lay social resources for support of adherence to Antiretroviral Prophylaxis for HIV prevention among Serodiscordant couples in sub-Saharan Africa: a qualitative study.[19] Adherence to Antiretroviral Prophylaxis for HIV prevention: A substudy cohort within a clinical Trial of Serodiscordant couples in East Africa. The study established that low PrEP adherence was associated with sexual behavior, alcohol use, younger age, and length of PrEP use.[20] Others are risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-Agent Preexposure Prophylaxis.[21] Intimate partner violence and adherence to HIV Pre-exposure Prophylaxis (PrEP) in African women in HIV Serodiscordant relationships: A prospective cohort study.[22]

See also

References

  1. ↑ Uganda State House (6 June 2016). "Museveni's new cabinet list At 6 June 2016" (PDF). Daily Monitor. Kampala. Archived from the original (PDF) on 7 October 2016. Retrieved 6 June 2016.
  2. ↑ Presidential Press Unit (1 March 2015). "President Museveni announces new Cabinet". Entebbe: Uganda State House. Retrieved 15 June 2016.
  3. ↑ "Tumwesigye wins Sheema municipality MP race". Daily Monitor. Retrieved 23 April 2019.
  4. ↑ Nakajubi, Gloria (25 July 2013). "New Health Minister Tumwesigye Reports for Work". New Vision (Kampala). Retrieved 1 March 2015.
  5. ↑ Uganda State House (1 March 2015). "Full Cabinet List As At 1 March 2015" (PDF). Daily Monitor (Kampala). Archived from the original (PDF) on 9 July 2017. Retrieved 1 March 2015.
  6. ↑ Newvision, Reporter (19 September 2014). "Ruhakana Rugunda New Prime Minister". New Vision (Kampala). Archived from the original on 10 May 2015. Retrieved 19 September 2014.
  7. 1 2 POU. "Profile of Tumwesigye Elioda, Member of Parliament for Sheema County North, Sheema District". Parliament of Uganda (POU). Archived from the original on 23 October 2015. Retrieved 1 March 2015.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  8. ↑ le Polain de Waroux, O.; Cohuet, S.; Ndazima, D.; Kucharski, A. J.; Juan-Giner, A.; Flasche, S.; Tumwesigye, E.; Arinaitwe, R.; Mwanga-Amumpaire, J.; Boum, Y.; Nackers, F.; Checchi, F.; Grais, R. F.; Edmunds, W. J. (11 April 2018). "Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda". BMC Infectious Diseases. 18 (1): 172. doi:10.1186/s12879-018-3073-1. ISSN 1471-2334. PMC 5896105. PMID 29642869.
  9. ↑ Psaros, Christina; Haberer, Jessica E.; Katabira, Elly; Ronald, Allan; Tumwesigye, Elioda; Campbell, James D.; Wangisi, Jonathan; Mugwanya, Kenneth; Kintu, Alex; Enyakoit, Michael; Thomas, Katherine K.; Donnell, Deborah; Krows, Meighan; Kidoguchi, Lara; Ware, Norma (15 August 2014). "An Intervention to Support HIV Preexposure Prophylaxis Adherence in HIV-Serodiscordant Couples in Uganda". Journal of Acquired Immune Deficiency Syndromes. 66 (5): 522–529. doi:10.1097/QAI.0000000000000212. ISSN 1525-4135. PMC 4191829. PMID 24853311.
  10. ↑ Heffron, Renee; McClelland, R Scott; Balkus, Jennifer E; Celum, Connie; Cohen, Craig R; Mugo, Nelly; Bukusi, Elizabeth; Donnell, Deborah; Lingappa, Jairam; Kiarie, James; Fiedler, Tina; Munch, Matthew; Fredricks, David N; Baeten, Jared M; Celum, Connie (1 October 2017). "Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study". The Lancet HIV. 4 (10): e449–e456. doi:10.1016/S2352-3018(17)30110-8. ISSN 2352-3018. PMC 5649365. PMID 28732773.
  11. ↑ Mugwanya, Kenneth (2016). "Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women". Journal of Infectious Diseases. pp. 1050–1057. doi:10.1093/infdis/jiw125. PMC 5021224. PMID 27029778. Retrieved 31 January 2023.
  12. ↑ Matthews, Lynn T; Orrell, Catherine; Bwana, Mwebesa Bosco; Tsai, Alexander C; Psaros, Christina; Asiimwe, Stephen; Amanyire, Gideon; Musinguzi, Nicholas; Bell, Kathleen; Bangsberg, David R; Haberer, Jessica E; the META Study Investigators; April, Nomakhaya; Mpahleni, Alienah; Situlo, Vivie (2020). "Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12‐month cohort study in urban South Africa and rural Uganda". Journal of the International AIDS Society. 23 (8): e25586. doi:10.1002/jia2.25586. ISSN 1758-2652. PMC 7441010. PMID 32820622.
  13. ↑ Tumwebaze, Henry; Tumwesigye, Elioda; Baeten, Jared M.; Kurth, Ann E.; Revall, Jennifer; Murnane, Pamela M.; Chang, Larry W.; Celum, Connie (13 December 2012). "Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation". PLOS ONE. 7 (12): e51620. Bibcode:2012PLoSO...751620T. doi:10.1371/journal.pone.0051620. ISSN 1932-6203. PMC 3521653. PMID 23272125.
  14. ↑ Mujugira, Andrew; Celum, Connie; Thomas, Katherine K.; Farquhar, Carey; Mugo, Nelly; Katabira, Elly; Bukusi, Elizabeth A.; Tumwesigye, Elioda; Baeten, Jared M. (1 August 2014). "Delay of Antiretroviral Therapy Initiation Is Common in East African HIV-Infected Individuals in Serodiscordant Partnerships". Journal of Acquired Immune Deficiency Syndromes. 66 (4): 436–442. doi:10.1097/QAI.0000000000000192. ISSN 1525-4135. PMC 4077929. PMID 24798765.
  15. ↑ Ndase, Patrick; Celum, Connie; Campbell, James; Bukusi, Elizabeth; Kiarie, James; Katabira, Elly; Mugo, Nelly; Tumwesigye, Elioda; Wangisi, Jonathan; Were, Edwin; Brantley, Justin; Donnell, Deborah; Baeten, Jared M. (1 June 2014). "Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result: The Partners PrEP Study Experience". Journal of Acquired Immune Deficiency Syndromes. 66 (2): 206–212. doi:10.1097/QAI.0000000000000141. ISSN 1525-4135. PMID 24828268. S2CID 38969652.
  16. ↑ Nuwaha, Fred; Kasasa, Simon; Wana, Godwill; Muganzi, Elly; Tumwesigye, Elioda (4 June 2012). "Effect of home-based HIV counselling and testing on stigma and risky sexual behaviours: serial cross-sectional studies in Uganda". Journal of the International AIDS Society. 15 (2): 17423. doi:10.7448/IAS.15.2.17423. ISSN 1758-2652. PMC 3499790. PMID 22713257.
  17. ↑ Baeten, Jared M.; Donnell, Deborah; Ndase, Patrick; Mugo, Nelly R.; Campbell, James D.; Wangisi, Jonathan; Tappero, Jordan W.; Bukusi, Elizabeth A.; Cohen, Craig R.; Katabira, Elly; Ronald, Allan; Tumwesigye, Elioda; Were, Edwin; Fife, Kenneth H.; Kiarie, James (2 August 2012). "Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women". New England Journal of Medicine. 367 (5): 399–410. doi:10.1056/NEJMoa1108524. ISSN 0028-4793. PMC 3770474. PMID 22784037.
  18. ↑ Ware, Norma C.; Wyatt, Monique A.; Haberer, Jessica E.; Baeten, Jared M.; Kintu, Alexander; Psaros, Christina; Safren, Steven; Tumwesigye, Elioda; Celum, Connie L.; Bangsberg, David R. (15 April 2012). "What's Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-Exposure Prophylaxis for HIV-Serodiscordant Couples". Journal of Acquired Immune Deficiency Syndromes. 59 (5): 463–468. doi:10.1097/QAI.0b013e31824a060b. ISSN 1525-4135. PMC 3826169. PMID 22267018.
  19. ↑ Ware, Norma C.; Pisarski, Emily E.; Haberer, Jessica E.; Wyatt, Monique A.; Tumwesigye, Elioda; Baeten, Jared M.; Celum, Connie L.; Bangsberg, David R. (1 May 2015). "Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study". AIDS and Behavior. 19 (5): 811–820. doi:10.1007/s10461-014-0899-4. ISSN 1573-3254. PMC 4415942. PMID 25267114.
  20. ↑ Haberer, Jessica E.; Baeten, Jared M.; Campbell, James; Wangisi, Jonathan; Katabira, Elly; Ronald, Allan; Tumwesigye, Elioda; Psaros, Christina; Safren, Steven A.; Ware, Norma C.; Thomas, Katherine K.; Donnell, Deborah; Krows, Meighan; Kidoguchi, Lara; Celum, Connie (10 September 2013). "Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa". PLOS Medicine. 10 (9): e1001511. doi:10.1371/journal.pmed.1001511. ISSN 1549-1676. PMC 3769210. PMID 24058300.
  21. ↑ Lehman, Dara A. (2015). "Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis". Journal of Infectious Diseases. pp. 1211–1218. doi:10.1093/infdis/jiu677. PMC 4402339. PMID 25587020. Retrieved 31 January 2023.
  22. ↑ Roberts, Sarah T.; Haberer, Jessica; Celum, Connie; Mugo, Nelly; Ware, Norma C.; Cohen, Craig R.; Tappero, Jordan W.; Kiarie, James; Ronald, Allan; Mujugira, Andrew; Tumwesigye, Elioda; Were, Edwin; Irungu, Elizabeth; Baeten, Jared M.; for the Partners PrEP Study Team (1 November 2016). "Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study". Journal of Acquired Immune Deficiency Syndromes. 73 (3): 313–322. doi:10.1097/QAI.0000000000001093. ISSN 1525-4135. PMC 5065369. PMID 27243900.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.